Drug Trial Radar · NCT01012297
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
Last checked: Nov 20, 2026Latest source record: Jun 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
107
Actual
Start
Nov 2009
Primary completion
Sep 2015
Study completion Sep 2015
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- Collaborators
- NRG Oncology
- First posted
- Nov 13, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial is studying gemcitabine hydrochloride, docetaxel, and bevacizumab to see how well they work compared with gemcitabine hydrochloride, docetaxel, and a placebo in treating patients with advanced or recurrent uterine leiomyosarcoma. Drugs used in chemotherapy, such as gemcitabine hydrochloride and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. It is not yet known whether gemcitabine hydrochloride and docetaxel are more effective when given with or without bevacizumab in treating uterine leiomyosarcoma.
Conditions
- Recurrent Uterine Corpus Sarcoma
- Stage IIIA Uterine Sarcoma
- Stage IIIB Uterine Sarcoma
- Stage IIIC Uterine Sarcoma
- Stage IVA Uterine Sarcoma
- Stage IVB Uterine Sarcoma
- Uterine Corpus Leiomyosarcoma
Interventions
BevacizumabBiological
Given IV
DocetaxelDrug
Given IV
FilgrastimBiological
Given SC
Gemcitabine HydrochlorideDrug
Given IV
PegfilgrastimBiological
Given SC
PlaceboOther
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free SurvivalTime frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months
Locations
201 sites in 1 country. Site status is shown where the registry gives one.
Saint Joseph's Hospital and Medical Center
Phoenix, Arizona
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
John Muir Medical Center-Concord Campus
Concord, California
UC San Diego Moores Cancer Center
La Jolla, California
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California
Los Angeles County-USC Medical Center
Los Angeles, California
USC / Norris Comprehensive Cancer Center
Los Angeles, California
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California
Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California
University of California San Diego
San Diego, California
UCSF Medical Center-Mount Zion
San Francisco, California
Olive View-University of California Los Angeles Medical Center
Sylmar, California
John Muir Medical Center-Walnut Creek
Walnut Creek, California
The Medical Center of Aurora
Aurora, Colorado
University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado
Boulder Community Hospital
Boulder, Colorado
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
Porter Adventist Hospital
Denver, Colorado
Exempla Saint Joseph Hospital
Denver, Colorado
Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado
Rose Medical Center
Denver, Colorado
Colorado Cancer Research Program CCOP
Denver, Colorado
Rocky Mountain Gynecologic Oncology PC
Englewood, Colorado
Swedish Medical Center
Englewood, Colorado
Saint Mary's Hospital and Regional Medical Center
Grand Junction, Colorado
North Colorado Medical Center
Greeley, Colorado
Saint Anthony Hospital
Lakewood, Colorado
Littleton Adventist Hospital
Littleton, Colorado
Sky Ridge Medical Center
Lone Tree, Colorado
Longmont United Hospital
Longmont, Colorado
McKee Medical Center
Loveland, Colorado
Parker Adventist Hospital
Parker, Colorado
Saint Mary Corwin Medical Center
Pueblo, Colorado
North Suburban Medical Center
Thornton, Colorado
SCL Health Lutheran Medical Center
Wheat Ridge, Colorado
Hartford Hospital
Hartford, Connecticut
The Hospital of Central Connecticut
New Britain, Connecticut
Beebe Medical Center
Lewes, Delaware
Christiana Care Health System-Christiana Hospital
Newark, Delaware
Showing 40 of 201 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.